Literature DB >> 22173637

Linking metabolism and cell cycle progression via the APC/CCdh1 and SCFβTrCP ubiquitin ligases.

Shanshan Duan1, Michele Pagano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173637      PMCID: PMC3248501          DOI: 10.1073/pnas.1118443109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  The engine driving the ship: metabolic steering of cell proliferation and death.

Authors:  Marisa R Buchakjian; Sally Kornbluth
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

2.  The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.

Authors:  Angel Herrero-Mendez; Angeles Almeida; Emilio Fernández; Carolina Maestre; Salvador Moncada; Juan P Bolaños
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

3.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

4.  mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.

Authors:  Daming Gao; Hiroyuki Inuzuka; Meng-Kwang Marcus Tan; Hidefumi Fukushima; Jason W Locasale; Pengda Liu; Lixin Wan; Bo Zhai; Y Rebecca Chin; Shavali Shaik; Costas A Lyssiotis; Steven P Gygi; Alex Toker; Lewis C Cantley; John M Asara; J Wade Harper; Wenyi Wei
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

5.  mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR.

Authors:  Shanshan Duan; Jeffrey R Skaar; Shafi Kuchay; Alfredo Toschi; Naama Kanarek; Yinon Ben-Neriah; Michele Pagano
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

6.  E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation.

Authors:  Angeles Almeida; Juan P Bolaños; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 7.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

Review 8.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

Review 9.  Cycling through metabolism.

Authors:  Victor Aguilar; Lluis Fajas
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

Review 10.  Control of cell growth by the SCF and APC/C ubiquitin ligases.

Authors:  Jeffrey R Skaar; Michele Pagano
Journal:  Curr Opin Cell Biol       Date:  2009-09-21       Impact factor: 8.382

View more
  4 in total

Review 1.  Alternative fuels for cancer cells.

Authors:  Melissa M Keenan; Jen-Tsan Chi
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 2.  Ubiquitin ligases in cancer: Functions and clinical potentials.

Authors:  Shanshan Duan; Michele Pagano
Journal:  Cell Chem Biol       Date:  2021-05-10       Impact factor: 9.039

3.  IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3.

Authors:  Michael A Reid; Xazmin H Lowman; Min Pan; Thai Q Tran; Marc O Warmoes; Mari B Ishak Gabra; Ying Yang; Jason W Locasale; Mei Kong
Journal:  Genes Dev       Date:  2016-09-01       Impact factor: 11.361

4.  Targeting cellular metabolism to reduce head and neck cancer growth.

Authors:  Jian Yang; Yuqi Guo; Wonkyu Seo; Ruohan Zhang; Cuijie Lu; Yaoyu Wang; Liang Luo; Bidisha Paul; Wenbo Yan; Deepak Saxena; Xin Li
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.